| FUNDAMENTALS |
| MarketCap: |
0.0044 mill
|
| EPS: |
-0.0700
|
| P/E: |
-0.0014
|
| Earnings Date: |
N/A |
| SharesOutstanding: |
44.28 mill
|
| Avg Daily Volume: |
0.0036 mill
|
| RATINGS |
| Rating CashFlow: |
Strong Buy
|
|
| Return On Equity: |
Neutral
|
|
| Return On Asset: |
Buy
|
|
| DE: |
Sell
|
|
| P/E: |
Strong Buy
|
|
| Price To Book: |
Neutral
|
|
| QUARTER GROWTHS |
|
2/22 | 3/22 | 4/22 | 1/23 | 2/23 | 3/23 |
| Revenue | | | n/a | n/a | n/a | n/a |
| Gr.Profit | | | n/a | n/a | n/a | n/a |
| Ebit | | | n/a | n/a | n/a | n/a |
| Asset | | | n/a | n/a | n/a | n/a |
| Debt | | | n/a | n/a | n/a | n/a |
| PE RATIO: COMPANY / SECTOR |
|
0.00x
|
|
Company: PE -0.0014 | sector: PE -11.58
|
| PE RATIO: COMPANY / INDUSTRY |
|
0x
|
|
Company: PE -0.0014 | industry: PE -107.25
|
| DISCOUNTED CASH FLOW VALUE |
|
N/A
|
|
N/A
|
| Expected Trading Range (DAY) |
$ 0.0001 - 0.0001
( +/- 0.00%)
|
|
ATR Model: 14 days
|
Insider Trading
| Date |
Person |
Action |
Amount |
type |
| 2012-09-04 | Arnone John S | Buy | 800 000 | Employee Stock Option (right to buy) |
| 2012-09-04 | Dudzinski Anthony Francis | Buy | 580 000 | Employee Stock Option (right to buy) |
| 2011-04-21 | Arnone John S | Buy | 0 | Common Stock, (0.001 par value) |
| 2011-04-21 | Dudzinski Anthony Francis | Buy | 0 | Common Stock, (0.001 par value) |
| 2011-04-21 | Neill Christopher Joseph | Buy | 0 | Common Stock, (0.001 par value) |
| INSIDER POWER |
|
0.00
|
| Last
48 transactions |
| Buy:
9 066 028 | Sell:
158 566 631 |
Forecast:
01:40 - $0.0020
Live Trading Signals (every 1 min)
SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
| Indicator Signals |
| RSI 21 |
|
| SMA |
|
| Trend |
|
| Trend 2 |
|
| Trend 3 |
|
| MACD |
|
| Volume Signals |
| Price |
$0.0001 (-99.75% )
|
| Volume |
0.0188 mill
|
| Avg. Vol. |
0.0036 mill
|
| % of Avg. Vol |
524.62 %
|
| Signal 1: |
|
| Signal 2: |
|
Last 10 Buy & Sell Signals For CRYO
0 Signals |
Accuracy: 0.00% | Accuracy
Buy: 0.00% | Accuracy
Sell: 0.00%
Avg return
buy: 0.00 % | Avg return
sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
American CryoStem Corporation develops, markets, and licenses adipose tissue derived technologies for use in the fields of Regenerative and Personalized Medicine. The company's products include CELLECT collection, transportation, and storage system, which is a solution for physicians to collect and deliver tissue samples; ATGRAFT adipose tissue storage service, a fat collection, processing, and storage solution that enables physicians to provide their patients with tissue products and cell storage options; and ATCELL adipose derived stem cells. It also offers ACSelerat cell culture media products for growing human stromal cells. In addition, the company, provides contract manufacturing services for Autokine-CM, an anti-aging topical formulation; and autologous skin care product line. American CryoStem Corporation was founded in 1987 and is based in Eatontown, New Jersey.
The Technical Analyst
